News

Ankylosing spondylitis places a large financial burden on the German healthcare system, especially the costs of certain medications and patient hospitalizations, a study finds. The results, “Ankylosing spondylitis causes high burden to patients and the healthcare system: results from a German claims database analysis,” were published in…

Imagine living your whole life with a painful disease so rare that only 25 others worldwide have what you have. And that you’re one of just six such people who’ve made it to adulthood. Neena Nizar doesn’t have to imagine. The 41-year-old English professor at Metro Community College in Elkhorn,…

People who are diagnosed with ankylosing spondylitis (AS) are more likely to have had tonsillitis than those without this disease, a study found, suggesting that tonsillitis might predispose a person for AS. “Association between tonsillitis and newly diagnosed ankylosing spondylitis: A nationwide, population-based, case-control study” was published…

Yisaipu, a biosimilar of Enbrel (etanercept), has been approved in China as a pre-filled syringe to treat ankylosing spondylitis, among other conditions, announced the treatment’s developer, Sunshine Guojian Pharmaceutical, a subsidiary of 3SBio. Because lack of adherence to treatment may be a cause for repeated disease onset, this new…

Screening newborns for genetic diseases with treatments that can prevent crippling or deadly progression, especially for rare disorders, has a ways to go in the United States. No state today tests for all 35 disorders recommended under a federal screening panel, and even in those that come close, rare…

Oklahoma suffers more tornadoes than any other state, has the highest per-capita rate of women in U.S. prisons, ranks second in the number of teen births per 100,000 teenage girls, and has the nation’s third-highest rate of uninsured residents — with 13.9% of all Oklahomans lacking health coverage. As if…

Self-harm is more common in people diagnosed with ankylosing spondylitis compared with the general population, a study reveals, suggesting the need for better mental health monitoring and support for patients after such a diagnosis. The data were presented at the 2018 Annual European Congress of Rheumatology (EULAR) in a…

Hadlima (adalimumab-bwwd), a biosimilar to AbbVie’s Humira, has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of ankylosing spondylitis. The therapy was also approved for rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, adult Crohn’s disease, ulcerative colitis, and plaque psoriasis. A …

In Italy, Cosentyx (secukinumab) is a cost-saving treatment for ankylosing spondylitis, as well as for psoriatic arthritis and moderate to severe plaque psoriasis, according to a new study. The results were published in the journal ClinicoEconomics and Outcomes Research in a paper titled, “Budget impact…

Total hip replacement surgery, or hip arthroplasty, has doubled in older patients with ankylosing spondylitis (AS), outpacing the rates in the general population over recent years, a U.S. population-based study shows. AS patients who had this surgery had twice as many knee replacement interventions, compared to…